Air Liquide reinforces its activity in healthcare specialty ingredients with the acquisition of BiotechMarine by its subsidiary SEPPIC. BiotechMarine is a leading player in the design and marketing of active ingredients for the global cosmetics industry.
A subsidiary of the Roullier Group, BiotechMarine is a company that specialises in the design and marketing of bio-based, cosmetic active ingredients made fromalgae. BiotechMarine is based in the west of France, in the town of Pontrieux, and has 35 employees.
Since its creation in 1988, BiotechMarine has been recognised for its know-how. This company boasts a complete range of natural active ingredients sold all over the world, which are used in cosmetic products in particular. The acquisition of BiotechMarine will provide SEPPIC, a subsidiary in Air Liquide’s Healthcare Business Line, with complementary expertise in marine biotechnologies and plant cell culture. SEPPIC thus widens its product portfolio with a complete range of active ingredients from marine biodiversity.
Pascal Vinet, Vice President, Healthcare Global Operations and member of the group’s Executive Committee, commented: “We are delighted to welcome these new employees to the group. With this acquisition Air Liquide intends to reinforce its position in the field of healthcare specialty ingredients. The complementarity of BiotechMarine and SEPPIC allows us to widen our knowhow and continue the development of this activity. Health is one of the group’s growth drivers.”